PAVMED INC (PAVM)

Company Profile

PAVmed Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in New York City, New York and currently employs 124 full-time employees. The company went IPO on 2016-07-27. PAVmed Inc. is a multi-product, commercial-stage medical technology company. The firm operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.

Company Info

PAVMED INC

360 Madison Avenue, 25th Floor

New York City NEW YORK 10165

P: 12129494319

CEO: Lishan Aklog

Employees: 124

Website: https://pavmed.com/